|Day Low/High||927.50 / 938.60|
|52 Wk Low/High||565.05 / 789.87|
This tech giant is testing a key level at $1,000.
Global equity rally takes a breather.
The Dow Jones, S&P 500 and Nasdaq futures all fell slightly Sunday, each down about a tenth of a percent.
My three top predictions for the next six months.
Put your video game knowledge to the test. How much do you know about Nintendo's The Legend of Zelda
If you were reading TheStreet that day five years ago, here are three other stories you would have seen.
Anadarko has almost 40% upside. Abbott has 20% upside.
Many tech names were shaken Tuesday.
Alphabet's deal with Avis could lead to consumer acceptance of autonomous cars.
Cramer's take on these hot FAANGs.
AAPL is too pricey here, while FB and GOOGL would look better on a dip.
Warren Buffett is famous for being wary of investing in tech stocks.
U.K. Prime Minister Theresa May says technology companies have to do more to combat hate speech.
Tech momentum names don't put on much of a show.
MIT survey finds only 13% would feel comfortable in an automated vehicle.
Don't expect any meaningful change in the Russell 2000 ETF.
The nutritional supplements company on Monday unveiled a deal to sell to private equity firm HGGC in a transaction valued at about $446M, including debt to be refinanced.
Davids that follow Amazon's example may ultimately beat Goliath to the punch.
Inovio Pharmaceuticals, Neurocrine Biosciences and Alnylam Pharmaceuticals were among the biotech movers in premarket trading on Wednesday.
The U.S. auto supplier will integrate a self-driving system for BMW by 2021 that also will be for sale to rival automakers.
The board was prompted to act by Jana Partners, which has a 9% stake in the grocer.